Flu Clinical Trial
Official title:
Validation of the Efficiency of Molecules Reproposed on the Basis of Their Cellular Transcriptomic Signature, Antagonist of the Signature Determined in Infection Due to Virus Influenza A.
The aim of this study is to evaluate the possibility to repropose marketed drugs as antiviral ones, based on their ability to reverse the transcriptomic signature of the infected cells. This strategy has to be considered is the context of emerging viral diseases and of increase of resistance to antivirals. Concerning infection by Influenza viruses, the main drugs were identified and evaluated on in vitro and in vivo models: diltiazem. Therefore, it will be assess the efficacy of these the drug, compared to placebo, to treat severe flu.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT06057727 -
Behavioral Economics to Improve Flu Vaccination Using EHR Nudges
|
N/A | |
| Completed |
NCT03694808 -
FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care
|
Phase 4 | |
| Completed |
NCT06385821 -
A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus
|
Phase 3 | |
| Completed |
NCT01440205 -
Licensing Flu Shot Study
|
N/A | |
| Terminated |
NCT00769002 -
PET-CT Scans in Healthy Volunteers After Flu Vaccination
|
N/A | |
| Completed |
NCT03308825 -
Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines
|
Phase 4 | |
| Completed |
NCT03189537 -
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
|
Phase 3 | |
| Completed |
NCT01484522 -
Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth
|
N/A | |
| Completed |
NCT03344029 -
Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years
|
Phase 4 | |
| Completed |
NCT01459952 -
A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a Cold
|
Phase 3 | |
| Completed |
NCT00644540 -
Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study
|
Phase 2 | |
| Recruiting |
NCT06158659 -
Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula
|
N/A | |
| Completed |
NCT05417997 -
Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients
|
Phase 3 | |
| Completed |
NCT01389518 -
Efficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu Syndrome
|
Phase 3 | |
| Completed |
NCT02822105 -
Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers
|
Phase 1 | |
| Withdrawn |
NCT02037282 -
A Phase 1, Open Label, Ascending Dose Cohort Study of the Pharmacokinetics of Anti-Influenza Hyperimmune Intravenous Immunoglobulin in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03293979 -
Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis
|
||
| Completed |
NCT04153331 -
Burden of Influenza at Emergency Department Level : BIED
|
N/A | |
| Not yet recruiting |
NCT05473325 -
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
|
||
| Completed |
NCT01533220 -
Efficacy of Nasal Naphazoline Hydrocloride + Pheniramine Maleate + Panthenol Compared With Naphazoline Hydrocloride in the Symptomatic Control of Nasal Congestion and Nasopharyngeal
|
Phase 3 |